{"id":893069,"date":"2025-10-07T07:04:51","date_gmt":"2025-10-07T11:04:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/"},"modified":"2025-10-07T07:04:51","modified_gmt":"2025-10-07T11:04:51","slug":"pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/","title":{"rendered":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting"},"content":{"rendered":"

<\/p>\n

Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th<\/sup> European Association for Cardio-Thoracic Surgery Annual Meeting<\/b><\/p>\n

HAYWARD, Calif.–(BUSINESS WIRE<\/a>)–
\nPulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse\u2122 technology using its proprietary Nanosecond Pulsed Field Ablation\u2122 (nanosecond PFA or nsPFA\u2122) energy, today announced the upcoming presentation of early clinical data on the treatment of atrial fibrillation (AF) using the nPulse\u2122 Cardiac Surgical System at the 39th<\/sup> European Association for Cardio-Thoracic Surgery Annual Meeting from October 8-11th<\/sup> in Copenhagen, Denmark.<\/p>\n

\n\u201cThe FDA\u2019s recent approval of our IDE study for the nPulse\u2122 Cardiac Surgical System marks a significant milestone in the development of our novel technology for the treatment of atrial fibrillation,” said Paul LaViolette, Co-Chairman and CEO of Pulse Biosciences. \u201cWe are excited for the early clinical evidence supporting the safety and efficacy of nPulse\u2122 to be featured at the world\u2019s largest cardiothoracic surgery meeting and we appreciate the dedication of the clinicians continuing to evaluate and utilize our platform.\u201d<\/p>\n

\nEvents highlighting the nPulse\u2122 Cardiac Surgical System, using nanosecond PFA energy for the treatment of AF, include:<\/p>\n\n\n\n\n\n\n\n
\n

\nWednesday, October 8th<\/sup>, 2025<\/p>\n<\/td>\n<\/tr>\n

\n

Acquired Cardiac Techno-College \u2013 Part 1<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

Presentation | Pulsed Field Ablation (Live in a box 3D)<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nTime: 9:30am \u2013 12:30 pm (Presentation @ 10:40)<\/p>\n<\/td>\n<\/tr>\n

\n

\nLocation: Bella Center Copenhagen, Hall A1<\/p>\n<\/td>\n<\/tr>\n

\n

Bart van Putte, MD, St. Antonius Hospital, Nieuwegein, The Netherlands<\/i><\/p>\n<\/td>\n<\/tr>\n<\/table>\n\n\n\n\n\n\n
\n

\nFriday, October 10th<\/sup>, 2025<\/p>\n<\/td>\n<\/tr>\n

\n

Thoracic Moderated e-Poster Presentation | First-In-Human Study Using Nanosecond Pulsed Field Ablation (nsPFA) for Surgical Left Atrial Box Isolation with Electroanatomical Mapping Follow-up<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nTime: 12:30pm \u2013 1:00 pm<\/p>\n<\/td>\n<\/tr>\n

\n

\nLocation: Bella Center Copenhagen, Moderated e-Poster Station 2<\/p>\n<\/td>\n<\/tr>\n

\n

Bart van Putte, MD, St. Antonius Hospital, Nieuwegein, The Netherlands<\/i><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

About Pulse Biosciences<\/b>\u00ae<\/p>\n

\nPulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as the potential to improve the quality of life for patients. The Company\u2019s proprietary nPulse\u2122 technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its nPulse technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation.<\/p>\n

\nPulse Biosciences, nPulse, Vybrance, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA, nanosecond PFA and the stylized logos are among the trademarks and\/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nAll statements in this press release that are not historical are forward-looking statements, including, among other things, statements concerning early clinical successes and whether they are predictive of the safety and effectiveness of any medical device, such as the nPulse Cardiac Surgical System, statements concerning the Company\u2019s future clinical and regulatory initiatives anywhere in the world, and other future events. These statements are not historical facts but rather are based on Pulse Biosciences\u2019 current expectations, estimates, and projections regarding Pulse Biosciences\u2019 business, operations and other similar or related factors. Words such as \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201canticipate,\u201d \u201cpredict,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d \u201cexpects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cprojects,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences\u2019 control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences\u2019 filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251007750011\/en\/<\/a><\/span><\/p>\n

Investors:
\n<\/b>
Pulse Biosciences, Inc.
\n
Jon Skinner, CFO
\n
IR@pulsebiosciences.com<\/a><\/p>\n

Or
\n<\/b>
Gilmartin Group
\n
Philip Trip Taylor
\n
415.937.5406
\n
philip@gilmartinir.com<\/a><\/p>\n

KEYWORDS:<\/b> California Netherlands North America United States Europe Denmark<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Medical Devices Surgery Health Technology Clinical Trials Cardiology Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting HAYWARD, Calif.–(BUSINESS WIRE)– Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse\u2122 technology using its proprietary Nanosecond Pulsed Field Ablation\u2122 (nanosecond PFA or nsPFA\u2122) energy, today announced the upcoming presentation of early clinical data on the treatment of atrial fibrillation (AF) using the nPulse\u2122 Cardiac Surgical System at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting from October 8-11th in Copenhagen, Denmark. \u201cThe FDA\u2019s recent approval of our IDE study for the nPulse\u2122 Cardiac Surgical System marks a significant milestone in the development of our novel technology for the treatment of atrial fibrillation,” … <\/p>\n

Continue reading “Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-893069","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting HAYWARD, Calif.–(BUSINESS WIRE)– Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse\u2122 technology using its proprietary Nanosecond Pulsed Field Ablation\u2122 (nanosecond PFA or nsPFA\u2122) energy, today announced the upcoming presentation of early clinical data on the treatment of atrial fibrillation (AF) using the nPulse\u2122 Cardiac Surgical System at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting from October 8-11th in Copenhagen, Denmark. \u201cThe FDA\u2019s recent approval of our IDE study for the nPulse\u2122 Cardiac Surgical System marks a significant milestone in the development of our novel technology for the treatment of atrial fibrillation,” … Continue reading "Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T11:04:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting\",\"datePublished\":\"2025-10-07T11:04:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/\"},\"wordCount\":712,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/\",\"name\":\"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-10-07T11:04:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Market Newsdesk","og_description":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting HAYWARD, Calif.–(BUSINESS WIRE)– Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse\u2122 technology using its proprietary Nanosecond Pulsed Field Ablation\u2122 (nanosecond PFA or nsPFA\u2122) energy, today announced the upcoming presentation of early clinical data on the treatment of atrial fibrillation (AF) using the nPulse\u2122 Cardiac Surgical System at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting from October 8-11th in Copenhagen, Denmark. \u201cThe FDA\u2019s recent approval of our IDE study for the nPulse\u2122 Cardiac Surgical System marks a significant milestone in the development of our novel technology for the treatment of atrial fibrillation,” … Continue reading \"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-07T11:04:51+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting","datePublished":"2025-10-07T11:04:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/"},"wordCount":712,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/","name":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-10-07T11:04:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007750011r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulse-biosciences-announces-clinical-data-highlighting-its-npulse-cardiac-surgical-system-to-be-presented-at-the-39th-european-association-for-cardio-thoracic-surgery-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pulse Biosciences Announces Clinical Data Highlighting its nPulse\u2122 Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/893069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=893069"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/893069\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=893069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=893069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=893069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}